DoP asks NPPA to review, verify Bharat Serum and Vaccine’s request of revising ceiling price of Human Normal Immunoglobulin Read more
DoP organises meeting with industry associations to discuss implementation of Phase II PLI scheme Read more
DoP forms expert committee to identify investment opportunities, bottlenecks in pharma industry Read more